Clarithromycin: all 173 studies that test it
Page 1 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori InfectionRecruitingNCT07293910Phase 2
- Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori InfectionRecruitingNCT07275827Phase 3
- Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT LymphomaNot yet recruitingNCT07144657Phase 2
- Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori InfectionNot yet recruitingNCT07040839Phase 4
- Comparison of Two Treatment Regimens of Helicobacter Pylori InfectionNot yet recruitingNCT07021729Phase 4
- Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)RecruitingNCT06396078Phase 4
- Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)RecruitingNCT06294600Phase 3
- A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of ChileRecruitingNCT05926804Not applicable
- Helicobacter Pylori Eradication and Follow-upRecruitingNCT05061732Phase 4
- The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)CompletedNCT05845567Phase 1Results posted
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy ParticipantsCompletedNCT05469126Phase 1Results posted
- Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma PatientsTerminatedNCT04843579Phase 2Results posted
- A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to DaratumumabActive, not recruitingNCT04302324Phase 2Results posted
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori InfectionCompletedNCT04167670Phase 3Results posted
- Clarithromycin Mechanisms in Hypersomnia SyndromesCompletedNCT04026958Phase 2Results posted
- Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil ArmCompletedNCT03440112Phase 1/2Results posted
- Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's DiseaseCompletedNCT03009396Phase 3Results posted
- Two Different Antibiotic Agents to Treat Generalized Aggressive PeriodontitisCompletedNCT02969928Phase 2/3Results posted
- Clarithromycin as Adjuvant to Periodontal DebridementCompletedNCT02829983Not applicableResults posted
- BiRd vs. Rd as Initial Therapy in Multiple MyelomaTerminatedNCT02516696Phase 3Results posted
- Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus SurgeryCompletedNCT02182492Not applicableResults posted
- A Study of LY2835219 in Participants With CancerCompletedNCT02117648Phase 1Results posted
- CYP3A4 Activity and Mineral HomeostasisCompletedNCT02019875Early Phase 1Results posted
- The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the BloodstreamCompletedNCT01836198Phase 1Results posted
- Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple MyelomaCompletedNCT01559935Phase 2Results posted
- A Study to Evaluate the Effect of Clarithromycin on LY2216684CompletedNCT01460407Phase 1Results posted
- Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or LymphomaCompletedNCT01454076Phase 1Results posted
- Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory MyelomaCompletedNCT01159574Phase 2Results posted
- Drug-Drug Interaction Study of Colchicine and ClarithromycinCompletedNCT00984061Phase 1Results posted
- Clarithromycin 500 mg Extended Release Tablets Under Fasting ConditionsCompletedNCT00840411Phase 1Results posted
- Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.CompletedNCT00840216Phase 1Results posted
- Clarithromycin 500 mg Tablets Under Non-Fasting ConditionsCompletedNCT00836706Phase 1Results posted
- Clarithromycin 500 mg Tablets Under Fasting ConditionsCompletedNCT00835692Phase 1Results posted
- Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple MyelomaCompletedNCT00538733Phase 2Results posted
- Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple MyelomaCompletedNCT00445692Phase 2Results posted
- Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)CompletedNCT00318708Phase 3Results posted
- Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OCActive, not recruitingNCT07341100Phase 2
- Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based StudyCompletedNCT07211880Not applicable
- Effects of Different Antibiotic Regimens in Preterm Premature Rupture of MembranesCompletedNCT07148622Not applicable
- Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy SubjectsCompletedNCT07040787Phase 1
- A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy AdultsCompletedNCT06837259Phase 1
- Drug-Drug Interactions Between TNP-2198 and Midazolam, ClarithromycinCompletedNCT06551623Phase 1
- Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in EgyptiansCompletedNCT06315478Phase 4
- A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult ParticipantsCompletedNCT06227832Phase 1
- Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy AdultsCompletedNCT05991401Phase 1
- A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy ParticipantsCompletedNCT05965570Phase 1
- Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and ClarithromycinCompletedNCT05915871Phase 1
- Electrophysiological Effects of Potential QT Prolonging DrugsCompletedNCT05716854Phase 1
- Susceptibility-Guided Therapy for Helicobacter Pylori Infection TreatmentWithdrawnNCT05250050Phase 4
- Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy VolunteersCompletedNCT05194046Phase 1
- 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid TherapyStatus unknownNCT05191888Phase 4
- A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy SubjectsCompletedNCT05137600Phase 1
- Bismuth-containing Quadruple Therapy for Helicobacter Pylori EradicationCompletedNCT05049902Phase 4
- Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic PatientsStatus unknownNCT05023577Phase 4
- Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 DaysStatus unknownNCT04901117Phase 4
- Anti-inflammatory Action of Oral Clarithromycin in Community-acquired PneumoniaCompletedNCT04724044Phase 3
- Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in ChildrenStatus unknownNCT04721704Not applicable
- Helicobacter Pylori Eradication in Functional DyspepsiaCompletedNCT04697641Not applicable
- Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian PopulationsStatus unknownNCT04658277Not applicable
- Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 InfectionCompletedNCT04622891Not applicable
- Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori InfectionCompletedNCT04621487Not applicable
- Comparing Different Regimens for Eradication of Helicobacter Pylori in KuwaitCompletedNCT04617613Phase 4
- Assessment and Management of Chronic Dyspepsia in Eastern UgandaCompletedNCT04525664Early Phase 1
- Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/BismuthStatus unknownNCT04444011Phase 1
- Anti-inflammatory Clarithromycin for Improving COVID-19 Infection EarlyCompletedNCT04398004Phase 2
- The Epidemiology and Optimal Treatment of Helicobacter Pylori in MyanmarCompletedNCT04132479Phase 4
- A Drug Interaction Study of KW-6356 and Clarithromycin or RifampicinCompletedNCT04070495Phase 1
- Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the CommunitySuspendedNCT03824847Phase 4
- A Study to Assess the Drug-Drug Interaction Between Bedaquiline and Clarithromycin in Healthy Adult ParticipantsCompletedNCT03800550Phase 1
- Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin AllergyCompletedNCT03708848Phase 4
- Genotypic Resistance Guided Therapy for Refractory H. Pylori InfectionStatus unknownNCT03555526Phase 4
- Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03516669Phase 4
- Triple Therapy With Tegoprazan in H. Pylori Positive PatientsCompletedNCT03498456Phase 3
- Safety Trial of Herbal Melanin in Gastritis PatientsStatus unknownNCT03428568Phase 2
- Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)Status unknownNCT03414918Not applicable
- Tailored Therapy for Helicobacter Pylori Rescue TreatmentCompletedNCT03413020Phase 4
- Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male VolunteersCompletedNCT03366974Phase 1
- Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune SystemCompletedNCT03345992Phase 3
- Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth TherapyStatus unknownNCT03321773Not applicable
- A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive PatientsCompletedNCT03317223Phase 3
- Sequential Versus Quadruple Therapy in the Second-line TreatmentStatus unknownNCT03208426Phase 4
- S. Aureus Decolonization in HPN Patients.TerminatedNCT03173053Not applicable
- Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic PurpuraStatus unknownNCT03172676Phase 4
- Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori TreatmentStatus unknownNCT03139253Phase 4
- 10 vs 14 Days Triple Therapy : H.Pylori Infection EradicationStatus unknownNCT03134378Phase 4
- Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive PeriodontitisCompletedNCT03132714Phase 2/3
- Intraluminal Therapy for Helicobacter Pylori InfectionCompletedNCT03124420Phase 4
- Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter PyloriCompletedNCT03108287Phase 4
- Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone LymphomaCompletedNCT03031483Phase 2
- Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.PyloriWithdrawnNCT03021590Phase 4
- To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose AdministrationCompletedNCT03011996Phase 1
- Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory MyelomaWithdrawnNCT02986451Phase 2
- Tailored Versus Empiric Therapy for Helicobacter Pylori TreatmentCompletedNCT02935010Phase 4
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCStatus unknownNCT02852083Phase 2
- To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy SubjectsCompletedNCT02807051Phase 1
- TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor ClarithromycinCompletedNCT02774902Phase 1
- The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori PatientsCompletedNCT02648659Phase 4
- Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple MyelomaStatus unknownNCT02624440Phase 2
- GEM-CLARIDEX: Ld vs BiRdStatus unknownNCT02575144Phase 3
- Clarithromycin in Multiple Myeloma Induction TherapyTerminatedNCT02573935Phase 2